+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Implantable Biomaterials Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5134298
  • Report
  • July 2020
  • Region: Global
  • 200 pages
  • The Business Research Company

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M
  • Bayer AG
  • CeramTec
  • Corbion
  • Invibio Ltd.
  • Royal DSM
Implantable Biomaterials Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global implantable biomaterials market.

This report focuses on implantable biomaterials market which is experiencing strong growth. The report gives a guide to the implantable biomaterials market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the implantable biomaterials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Implantable Biomaterials market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider implantable biomaterials market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The implantable biomaterials market section of the report gives context. It compares the implantable biomaterials market with other segments of the implantable biomaterials market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, implantable biomaterials indicators comparison.
Scope

Markets Covered:
1) By Material: Metallic; Ceramic; Polymers; Natural
2) By Application: Dental; Cardiovascular; Ophthalmology; Orthopedic; Others

Companies Mentioned: Evonik Industries AG; Royal DSM; Zimmer Biomet Holdings; Carpenter Technology Corporation; Collagen Matrix

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • Bayer AG
  • CeramTec
  • Corbion
  • Invibio Ltd.
  • Royal DSM
1. Executive Summary

2. Implantable Biomaterials Market Characteristics

3. Implantable Biomaterials Market Size And Growth
3.1. Global Implantable Biomaterials Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Implantable Biomaterials Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Implantable Biomaterials Market Segmentation
4.1. Global Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Metallic
  • Ceramic
  • Polymers
  • Natural
4.2. Global Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Dental
  • Cardiovascular
  • Ophthalmology
  • Orthopedic
  • Others
5. Implantable Biomaterials Market Regional And Country Analysis
5.1. Global Implantable Biomaterials Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Implantable Biomaterials Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Implantable Biomaterials Market
6.1. Asia-Pacific Implantable Biomaterials Market Overview
6.2. Asia-Pacific Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Implantable Biomaterials Market
7.1. China Implantable Biomaterials Market Overview
7.2. China Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Implantable Biomaterials Market
8.1. India Implantable Biomaterials Market Overview
8.2. India Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Implantable Biomaterials Market
9.1. Japan Implantable Biomaterials Market Overview
9.2. Japan Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Implantable Biomaterials Market
10.1. Australia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Implantable Biomaterials Market
11.1. Indonesia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Implantable Biomaterials Market
12.1. South Korea Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Implantable Biomaterials Market
13.1. Western Europe Implantable Biomaterials Market Overview
13.2. Western Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Implantable Biomaterials Market
14.1. UK Implantable Biomaterials Market Overview
14.2. UK Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Implantable Biomaterials Market
15.1. Germany Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Implantable Biomaterials Market
16.3. France Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Implantable Biomaterials Market
17.1. Eastern Europe Implantable Biomaterials Market Overview
17.2. Eastern Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Implantable Biomaterials Market
18.1. Russia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Implantable Biomaterials Market
19.1. North America Implantable Biomaterials Market Overview
19.2. North America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Implantable Biomaterials Market
20.1. USA Implantable Biomaterials Market Overview
20.2. USA Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Implantable Biomaterials Market
21.1. South America Implantable Biomaterials Market Overview
21.2. South America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Implantable Biomaterials Market
22.1. Brazil Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Implantable Biomaterials Market
23.1. Middle East Implantable Biomaterials Market Overview
23.2. Middle East Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Implantable Biomaterials Market
24.1. Africa Implantable Biomaterials Market Overview
24.2. Africa Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Implantable Biomaterials Market Competitive Landscape And Company Profiles
25.1. Implantable Biomaterials Market Competitive Landscape
25.2. Implantable Biomaterials Market Company Profiles
25.2.1. Evonik Industries AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Royal DSM
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Zimmer Biomet Holdings
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Carpenter Technology Corporation
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Collagen Matrix
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Implantable Biomaterials Market

27. Implantable Biomaterials Market Trends And Strategies

28. Implantable Biomaterials Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • Bayer AG
  • CeramTec
  • Corbion
  • Invibio Ltd.
  • Royal DSM
Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation.

The global implantable market is expected to decline from $108.8 billion in 2019 to $102.5 billion in 2020 at a compound annual growth rate (CAGR) of -5.79%. The decline is mainly due to the COVID-19 outbreak that has deferred non-emergency surgeries in order to attend critical patients suffering from COVID-19. The market is then expected to recover and reach $136.59 billion in 2023 at a CAGR of 10.04%.

The implantable biomaterials market consists of sales of implantable biomaterials and related services. A biomaterial is a natural or synthetic material that is used in medical applications to support, enhance, or replace the damaged tissue or a biological structure.

North America was the largest region in the implantable biomaterials market followed by Europe in 2019.

In August 2019, Linden, a US-based healthcare private equity firm, acquired Collagen Matrix Inc for an undisclosed amount. The acquisition is expected to be an operating partner-driven strategy and highlights their ongoing focus on medical products, and contract and private label manufacturing in dental and orthopedic sectors. Collagen Matrix is a collagen-based medical developer and manufacturer of orthopedic biomaterials.

The implantable biomaterials market covered in this report is segmented by material into metallic; ceramic; polymers; natural and by application into dental; cardiovascular; ophthalmology; orthopedic; others.

Limitations of biomaterial-based products is a major challenge for the implantable biomaterials market. For instance, metal biomaterials can corrode due to chemical reactions within the body such as enzymes and acids or it can also cause some metal ion toxicity in the body. Polymer biomaterial implants have intensive interaction with the body and can lead to wear and tear and can absorb the important nutrients and water from the blood. Some biomaterial implants can also minimize bone ingrowth or sometimes, implants can loosen over time and become dislodged. These reactions that biomaterials have with the body restrain their use thereby negatively impacting the implantable biomaterials market's growth.

Major companies in the implantable biomaterials market are implementing 3D printing of biomaterials in manufacturing. For instance, Evonik is producing 3D printable biomaterials for medical technology that are used for manufacturing medical implants with permanent body contact and temporary body contactline of bioresorbable filaments and powders. Implants with permanent body contact are based on VESTAKEEP PEEK, and with temporary body contact are based on RESOMER.

The allocation of funds by government organizations in the development of new biomaterials contributed to the implantable biomaterials market's growth. For instance, in 2017, the UK regenerative platform received $21 million in the span of five years from the joint initiative between the three councils Medical Research Council(MRC), Engineering and Physical Science Research Council (EPSRC) and Biotechnology and Biological Sciences Research Council (BBSRC), in tissue engineering, stem cell biology, biomaterials, and nanoscience bioengineering. The support from government organizations in the development of new biomaterials will drive the implantable biomaterials market.
Note: Product cover images may vary from those shown
  • Evonik Industries AG
  • Royal DSM
  • Zimmer Biomet Holdings
  • Carpenter Technology Corporation
  • Collagen Matrix
  • Corbion
  • BASF SE
  • Invibio Ltd.
  • Celanese Corporation
  • Cam Bioceramics B.V.
  • E. I. DU PONT DE NEMOURS AND COMPANY
  • AdvanSource Biomaterials Corporation
  • Wright Medical Technology
  • Berkeley Advanced Biomaterials
  • Collagen solutions Plc
  • Keystone Dental
  • Surgival
  • SBM France
  • 3M
  • Biomet
  • Orthofix Holdings
  • Stryker Corporation
  • KLS martin and Medtronic
  • Arthrex
  • Aap Implantate AG
  • CoorsTek Inc.
  • CeramTec
  • GELITA AG
  • DePuy Synthes Companies
  • Bayer AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll